Literature DB >> 23502427

A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method.

David A Walker1, JoFen Liu, Mark Kieran, Nada Jabado, Susan Picton, Roger Packer, Christian St Rose.   

Abstract

Astrocytic tumors account for 42% of childhood brain tumors, arising in all anatomical regions and associated with neurofibromatosis type 1 (NF1) in 15%. Anatomical site determines the degree and risk of resectability; the more complete resection, the better the survival rates. New biological markers and modern radiotherapy techniques are altering the risk assessments of clinical decisions for tumor resection and biopsy. The increasingly distinct pediatric neuro-oncology multidisciplinary team (PNMDT) is developing a distinct evidence base. A multidisciplinary consensus conference on pediatric neurosurgery was held in February 2011, where 92 invited participants reviewed evidence for clinical management of hypothalamic chiasmatic glioma (HCLGG), diffuse intrinsic pontine glioma (DIPG), and high-grade glioma (HGG). Twenty-seven statements were drafted and subjected to online Delphi consensus voting by participants, seeking >70% agreement from >60% of respondents; where <70% consensus occurred, the statement was modified and resubmitted for voting. Twenty-seven statements meeting consensus criteria are reported. For HCLGG, statements describing overall therapeutic purpose and indications for biopsy, observation, or treatment aimed at limiting the risk of visual damage and the need for on-going clinical trials were made. Primary surgical resection was not recommended. For DIPG, biopsy was recommended to ascertain biological characteristics to enhance understanding and targeting of treatments, especially in clinical trials. For HGG, biopsy is essential, the World Health Organization classification was recommended; selection of surgical strategy to achieve gross total resection in a single or multistep process should be discussed with the PNMDT and integrated with trials based drug strategies for adjuvant therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23502427      PMCID: PMC3607269          DOI: 10.1093/neuonc/nos330

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  8 in total

Review 1.  Consensus methods for medical and health services research.

Authors:  J Jones; D Hunter
Journal:  BMJ       Date:  1995-08-05

Review 2.  Consensus development methods, and their use in clinical guideline development.

Authors:  M K Murphy; N A Black; D L Lamping; C M McKee; C F Sanderson; J Askham; T Marteau
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

3.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).

Authors:  Tore Stokland; Jo-Fen Liu; James W Ironside; David W Ellison; Roger Taylor; Kathryn J Robinson; Susan V Picton; David A Walker
Journal:  Neuro Oncol       Date:  2010-09-22       Impact factor: 12.300

Review 4.  The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour.

Authors:  Sophie Wilne; Karin Koller; Jacqueline Collier; Colin Kennedy; Richard Grundy; David Walker
Journal:  Arch Dis Child       Date:  2010-04-06       Impact factor: 3.791

5.  Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

Authors:  R Listernick; D N Louis; R J Packer; D H Gutmann
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

Review 6.  Practical decisions in the treatment of pediatric brain stem tumors.

Authors:  F Epstein; S Constantini
Journal:  Pediatr Neurosurg       Date:  1996       Impact factor: 1.162

7.  Radiological classification of optic pathway gliomas: experience of a modified functional classification system.

Authors:  T Taylor; T Jaspan; G Milano; R Gregson; T Parker; T Ritzmann; C Benson; D Walker
Journal:  Br J Radiol       Date:  2008-10       Impact factor: 3.039

8.  Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.

Authors:  J H Wisoff; J M Boyett; M S Berger; C Brant; H Li; A J Yates; P McGuire-Cullen; P A Turski; L N Sutton; J C Allen; R J Packer; J L Finlay
Journal:  J Neurosurg       Date:  1998-07       Impact factor: 5.115

  8 in total
  46 in total

1.  White matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade glioma.

Authors:  Fang Liu; Nadia Scantlebury; Uri Tabori; Eric Bouffet; Suzanne Laughlin; Douglas Strother; Dina McConnell; Juliette Hukin; Chris Fryer; Marie-Eve Brière; Isabelle Montour-Proulx; Daniel Keene; Frank Wang; Donald J Mabbott
Journal:  Neuro Oncol       Date:  2014-11-13       Impact factor: 12.300

2.  Neurofibromatosis 1-associated optic pathway gliomas.

Authors:  Ben Shofty; Liat Ben Sira; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-11       Impact factor: 1.475

3.  Neuro-oncology: paediatric brain tumours--when to operate?

Authors:  Kaisorn L Chaichana; Alfredo Quinones-Hinojosa
Journal:  Nat Rev Neurol       Date:  2013-05-28       Impact factor: 42.937

Review 4.  Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.

Authors:  Adam L Green; Mark W Kieran
Journal:  Curr Oncol Rep       Date:  2015-03       Impact factor: 5.075

5.  Cavernous malformation of the optic pathway mimicking optic glioma: a case report.

Authors:  Yui Mano; Toshihiro Kumabe; Ryuta Saito; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2014-07-03       Impact factor: 1.475

Review 6.  Diffuse intrinsic pontine glioma: a reassessment.

Authors:  Nathan J Robison; Mark W Kieran
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

7.  Accuracy of apparent diffusion coefficient values and magnetic resonance imaging in differentiating suprasellar germinomas from chiasmatic/hypothalamic gliomas.

Authors:  Theeraphol Panyaping; Piyakarn Taebunpakul; Oranan Tritanon
Journal:  Neuroradiol J       Date:  2020-03-20

8.  New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.

Authors:  Eric Raabe; Mark W Kieran; Kenneth J Cohen
Journal:  Clin Cancer Res       Date:  2013-07-23       Impact factor: 12.531

9.  Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases.

Authors:  Santhosh A Upadhyaya; Giles W Robinson; Julie H Harreld; Paul D Klimo; Mary Ellen Hoehn; Brent A Orr; Ibrahim A Qaddoumi
Journal:  Childs Nerv Syst       Date:  2018-02-01       Impact factor: 1.475

10.  Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.

Authors:  Stefano Gabriele Vallero; Daniele Bertin; Maria Eleonora Basso; Laura Stefania Pittana; Anna Mussano; Franca Fagioli
Journal:  Childs Nerv Syst       Date:  2014-01-14       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.